| Paroxysmal Nocturnal Hemoglobinuria |
1 |
1 |
| Hemolysis |
0 |
0.69 |
| Blood |
0 |
0.61 |
| Blood Transfusion |
0 |
0.48 |
| Thrombus |
0 |
0.48 |
| Patient Safety |
0 |
0.41 |
| Thromboembolism |
0 |
0.41 |
| Biliary Disease |
0 |
0.35 |
| Bone Marrow |
0 |
0.22 |
| COVID-19 |
0 |
0.2 |
| Diarrhea |
0 |
0.2 |
| Headache |
0 |
0.2 |
| Revenue and Practice Management |
0 |
0.2 |
| Anemia |
0 |
0.15 |
| Bone |
0 |
0.15 |
| Transfusion |
0 |
0.15 |
| Adverse Effects |
0 |
0.08 |
| Arthralgia |
0 |
0.08 |
| Cholecystitis |
0 |
0.08 |
| Hemoglobin |
0 |
0.08 |
| Liver |
0 |
0.08 |
| Nausea |
0 |
0.08 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.08 |
| Spleen |
0 |
0.08 |
| Thrombosis |
0 |
0.08 |